Lysophosphatidylserine enhances exogenous type II phospholipase A2-induced activation of rat serosal mast cells

Biol Pharm Bull. 1996 Mar;19(3):474-6. doi: 10.1248/bpb.19.474.

Abstract

We have previously shown that exogenous type II phospholipase A2 (PLA2) alone elicits degranulation of mast cells, including rat serosal mast cells (SMC) and mouse bone marrow-derived mast cells (BMMC). Here we report that lysophosphatidylserine (lysoPS), a co-factor for activation of rodent SMC in response to some tyrosine kinase-coupled agonists, enhanced type II PLA2-elicited histamine release from rat SMC. In contrast, mouse BMMC was insensitive to lysoPS. Our findings demonstrate a novel route for activation of SMC in that type II PLA2 can act as a direct activator of SMC with enhancement by lysoPS, which is generated from membrane phosphatidylserine possibly by the action of the same enzyme.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Degranulation / drug effects
  • Histamine Release / drug effects
  • In Vitro Techniques
  • Lysophospholipids / pharmacology*
  • Male
  • Mast Cells / drug effects*
  • Mice
  • Phospholipases A / pharmacology*
  • Phospholipases A2
  • Rats
  • Rats, Wistar

Substances

  • Lysophospholipids
  • lysophosphatidylserine
  • Phospholipases A
  • Phospholipases A2